138 related articles for article (PubMed ID: 12205821)
1. Treatment compliance and outcome in obsessive-compulsive disorder.
Abramowitz JS; Franklin ME; Zoellner LA; DiBernardo CL
Behav Modif; 2002 Sep; 26(4):447-63. PubMed ID: 12205821
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples.
Franklin ME; Abramowitz JS; Kozak MJ; Levitt JT; Foa EB
J Consult Clin Psychol; 2000 Aug; 68(4):594-602. PubMed ID: 10965635
[TBL] [Abstract][Full Text] [Related]
3. Patient adherence and treatment outcome with exposure and response prevention for OCD: Which components of adherence matter and who becomes well?
Wheaton MG; Galfalvy H; Steinman SA; Wall MM; Foa EB; Simpson HB
Behav Res Ther; 2016 Oct; 85():6-12. PubMed ID: 27497840
[TBL] [Abstract][Full Text] [Related]
4. EFFECTS OF HOMEWORK COMPLIANCE ON COGNITIVE-BEHAVIORAL THERAPY WITH D-CYCLOSERINE AUGMENTATION FOR CHILDREN WITH OBSESSIVE COMPULSIVE DISORDER.
Olatunji BO; Rosenfield D; Monzani B; Krebs G; Heyman I; Turner C; Isomura K; Mataix-Cols D
Depress Anxiety; 2015 Dec; 32(12):935-43. PubMed ID: 26372401
[TBL] [Abstract][Full Text] [Related]
5. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
[TBL] [Abstract][Full Text] [Related]
6. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
[TBL] [Abstract][Full Text] [Related]
7. Cognitive Mediation of Symptom Change in Exposure and Response Prevention for Obsessive-Compulsive Disorder.
Su YJ; Carpenter JK; Zandberg LJ; Simpson HB; Foa EB
Behav Ther; 2016 Jul; 47(4):474-86. PubMed ID: 27423164
[TBL] [Abstract][Full Text] [Related]
8. Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorder.
Simpson HB; Foa EB; Wheaton MG; Gallagher T; Gershkovich M; Schmidt AB; Huppert JD; Campeas RB; Imms PA; Cahill SP; DiChiara C; Tsao SD; Puliafico AC; Chazin D; Asnaani A; Moore K; Tyler J; Steinman SA; Sanchez-LaCay A; Capaldi S; Snorrason I; Turk-Karan E; Vermes D; Kalanthroff E; Pinto A; Hahn CG; Xu B; Van Meter PE; Katechis M; Scodes J; Wang Y
Behav Res Ther; 2021 Aug; 143():103890. PubMed ID: 34089924
[TBL] [Abstract][Full Text] [Related]
9. Does the therapy manual or the therapist matter most in treatment of obsessive-compulsive disorder? A randomized controlled trial of exposure with response or ritual prevention in 118 patients.
van Oppen P; van Balkom AJ; Smit JH; Schuurmans J; van Dyck R; Emmelkamp PM
J Clin Psychiatry; 2010 Sep; 71(9):1158-67. PubMed ID: 20361906
[TBL] [Abstract][Full Text] [Related]
10. Challenges using motivational interviewing as an adjunct to exposure therapy for obsessive-compulsive disorder.
Simpson HB; Zuckoff AM; Maher MJ; Page JR; Franklin ME; Foa EB; Schmidt AB; Wang Y
Behav Res Ther; 2010 Oct; 48(10):941-8. PubMed ID: 20609435
[TBL] [Abstract][Full Text] [Related]
11. Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial.
Mataix-Cols D; Marks IM; Greist JH; Kobak KA; Baer L
Psychother Psychosom; 2002; 71(5):255-62. PubMed ID: 12207105
[TBL] [Abstract][Full Text] [Related]
12. Patient adherence predicts outcome from cognitive behavioral therapy in obsessive-compulsive disorder.
Simpson HB; Maher MJ; Wang Y; Bao Y; Foa EB; Franklin M
J Consult Clin Psychol; 2011 Apr; 79(2):247-252. PubMed ID: 21355639
[TBL] [Abstract][Full Text] [Related]
13. Behavior therapy for obsessive compulsive disorder.
Greist JH
J Clin Psychiatry; 1994 Oct; 55 Suppl():60-8. PubMed ID: 7961534
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of exposure with response-prevention for obsessive compulsive disorder in childhood and adolescence.
Bolton D; Perrin S
J Behav Ther Exp Psychiatry; 2008 Mar; 39(1):11-22. PubMed ID: 17207457
[TBL] [Abstract][Full Text] [Related]
15. Comorbid posttraumatic stress disorder: impact on treatment outcome for obsessive-compulsive disorder.
Gershuny BS; Baer L; Jenike MA; Minichiello WE; Wilhelm S
Am J Psychiatry; 2002 May; 159(5):852-4. PubMed ID: 11986141
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical intention and anti-exposure in a non-compliant, obsessive-compulsive ritualiser.
Adshead G; Drummond LM; Mercer S
Br J Psychiatry; 1988 Dec; 153():821-3. PubMed ID: 3256383
[TBL] [Abstract][Full Text] [Related]
17. What predicts improvement and compliance during the behavioral treatment of obsessive compulsive disorder?
Buchanan AW; Meng KS; Marks IM
Anxiety; 1996; 2(1):22-7. PubMed ID: 9160595
[TBL] [Abstract][Full Text] [Related]
18. Behavior therapy for obsessive compulsive disorder.
Dar R; Greist JH
Psychiatr Clin North Am; 1992 Dec; 15(4):885-94. PubMed ID: 1461803
[TBL] [Abstract][Full Text] [Related]
19. How effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis.
Fisher PL; Wells A
Behav Res Ther; 2005 Dec; 43(12):1543-58. PubMed ID: 16239151
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
Wilhelm S; Buhlmann U; Tolin DF; Meunier SA; Pearlson GD; Reese HE; Cannistraro P; Jenike MA; Rauch SL
Am J Psychiatry; 2008 Mar; 165(3):335-41; quiz 409. PubMed ID: 18245177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
